Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials

Abstract

BackgroundThe studies on the effectiveness of Chinese herbal medicines (CHM) in treating liver fibrosis (LF) were not consistent. This study aims to systematically review the effectiveness of CHM on treating LF patients.MethodsDatabases including MEDLINE, AMED, EMBASE, The Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, TCMOnline, Chinese Biomedical Literature Database, and Chinese Medical Current Contents were searched up to March 2011. Randomized controlled trials (RCTs) involving LF patients receiving CHM, Western medicine, combined CHM and Western medicine compared with placebo, Western medicine or no intervention were included. LF markers including serum hyaluronic acid (HA), laminin (LN), procollagen type III (PC-III), type IV collagen (IV-C), matrix metalloproteinase (MMP), and tissue inhibitors of metalloproteinase (TIMP) were measured as primary outcomes. Liver biochemistry, including alanine aminotransferase (ALT) and aspartarte aminotransferase (AST), and improvement of related clinical symptoms were measured as secondary outcomes. Risk of bias of allocation sequence, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other biases were assessed.ResultsTwenty-three RCTs with 2123 participants were analyzed in subgroups of types of comparison and study quality. Fifteen studies were graded as good quality. CHM alone and combined with Western medicine showed significant improvements in HA, LN, PC-III and IV-C compared with Western medicine alone. However, there were no significant differences observed between CHM and placebo treatments.ConclusionThe current inconclusive results in determining the effectiveness of CHM treatment on LF, due to the poor methodological quality and high heterogeneity of the studies, suggests that large RCTs using standardized Chinese medicine syndrome diagnosis and CHM formulae with longer follow-up are required for further evaluation.

The Role of Oxidative Stress and Antioxidants in Liver Diseases

“…Since liver is an essential organ for detoxification and metabolism, and all pharmaceuticals make their way to the liver, for storage and therefore it is more prone to damage [ 127 , 128 ]. Paracetamol is widely used to relieve pain and reduce fever.…”

A retrospective analysis of cirrhotic patients receiving Chinese herbal medicine in addition to conventional care: Survival and safety

“…The reviewers indicated that the common CHM formulas, including Fufang Biejia Ruangan, Decoction of Radix Salviae Milltorrhizae, Radix Astragali and Rhubarb, or Anluo Huaxian Pills, were as efficacious as conventional anti-cirrhosis drugs but with fewer reported adverse effects. However, the low quality of many of the trials puts these conclusions into question [8].…”

Antifibrogenic Influence of Mentha piperita L. Essential Oil against CCl4‐Induced Liver Fibrosis in Rats

“…Medicinal plants and their derivatives contain a wide variety of bioactive phytochemicals with a diverse pharmacological spectrum [ 10 , 11 ]. Essential oils constituents including terpenes, terpenoids, phenylpropenes, and other degradation products have been reported to exhibit strong antioxidant and anti-inflammatory activities [ 12 ].…”